Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Probiotic Supplements for Gut Health market: $2.6 Bn against $490 Mn in 2023, about 5.2 times as large.
China grows faster: 8.7% a year, against 5.2%. The gap still grows from $2.1 Bn to $3.1 Bn by 2033.
Clinical research: 82 active trials in the US, 109 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $2.6 Bn | $490 Mn |
| Market size, 2033 projected | $4.3 Bn | $1.1 Bn |
| Growth a year (CAGR) | 5.2% | 8.7% |
| Money added, 2023–2033 | $1.7 Bn | $639 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $7.50 | $0.35 |
| Active clinical trials | 82 | 109 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Probiotic Supplements for Gut Health market: $2.6 Bn against $490 Mn in 2023, about 5.2 times as large.
China grows faster: 8.7% a year, against 5.2%. The gap still grows from $2.1 Bn to $3.1 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.